In interviews as well as a panel at BIO’s annual meeting, investors and life sciences bankers predicted an acceleration in ...

Europe will need to rethink how it values ​and pays for innovative medicines or risk losing manufacturing ‌investments and clinical trials, the head of Europe's pharmaceutical industry lobby said on ...

Traditionally, compounding pharmacies exist to serve a small subset of patients who have specialized medical needs. But ...

Buying a fixer-upper can be a great decision - but Phil Spencer warns there are lots of pitfalls buyers need to be aware of ...

US President Donald Trump spoke on TV about his phone call with President of the Swiss Confederation Karin Keller-Sutter - and did not leave a good mark on her.

Multiple experts who reviewed the donation say the payment could qualify as a conflict because it has the potential to ...

Despite its massive $10.5 billion size and 12-drug scope, Pfizer’s oncology deal with Innovent Biologics took less than five ...

Fresh off the controversial Los Angeles mayoral election, Spencer Pratt said this is only the beginning in an exclusive ...

In this video interview, Marwan Fathallah, president and CEO of DIA Global, shares the key trends and themes shaping this ...

Legislator Joe Patterson has introduced a bill to create a working group to study and recommend use of certain peptides.

More than 85% of health plan actuaries surveyed for PwC's “Medical Cost Trend: Behind the Numbers 2027” report expect ...

Transaction diligence increasingly stress-tests supply chain integrity across the full patient journey for cell and gene ...